Gvh-682

: Studies in this cohort size have consistently shown that while GVHD severity is inversely correlated with leukemia relapse (the "Graft-versus-Leukemia" effect), severe GVHD (grades III–IV) remains a primary driver of Treatment-Related Mortality (TRM) [16, 27]. 🏥 Clinical Significance of GVHD

The code might be a transcription error. If you recall a related term (e.g., a book title, model number, or scientific concept), try correcting or expanding the search. For example: gvh-682

: Current prevention typically involves T-cell depletion or immunosuppressive drugs like steroids , though these can increase the risk of cancer relapse by dampening the "Graft-versus-Leukemia" effect [14]. : Studies in this cohort size have consistently

: Primarily affects the skin (rash), liver (jaundice), and gastrointestinal tract (diarrhea/bleeding) [5.1, 5.3]. a book title